Pierre Delobel - Infectious Diseases

Author Information

Pierre Delobel is a distinguished researcher specializing in infectious diseases. He is affiliated with the Department of Infectious and Tropical Diseases at Toulouse University Hospital, situated in Toulouse, France. Additionally, he holds a position at Paul Sabatier Toulouse III University and is involved with the Inserm U1043 - CNRS UMR 5282 at the Toulouse-Purpan Pathophysiology Center. His work primarily focuses on infectious diseases, and he has contributed significantly to the scientific community through his research endeavors.

Research Contributions

Pierre Delobel has made substantial contributions to the field of infectious diseases, as evidenced by his extensive publication record. His research encompasses a broad spectrum of topics, including HIV-1 infection, the impact of therapeutic interventions on viral loads, and the effectiveness of fecal microbiota transplantation for Clostridioides difficile infections. Notably, his work on the prevalence of cancers among people living with HIV and the immunogenicity of rabies vaccination further highlights his diverse research interests. His studies are crucial in enhancing the understanding of infectious diseases and improving treatment strategies.

Aliases

Pierre Delobel is known by several aliases in the academic community, including P Delobel and P. Delobel. These variations of his name are used interchangeably across different publications and citations.

Publication and Citation Metrics

Total Papers	194
Total Citations	4978
H-index	43

Publications:

HIV-1 infection induces functional reprogramming of female plasmacytoid dendritic cells associated with enhanced TLR7 expression

DOI:

Year: 2022

Impact of Casirivimab-Imdevimab on Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Nasopharyngeal Virus Load and Spike Quasispecies

DOI: 10.1093/ofid/ofac093

Year: 2022

Fecal Microbiota Transplantation for Refractory Clostridioides Difficile Infection Is Effective and Well Tolerated Even in Very Old Subjects: A Real-Life Study

DOI: 10.1007/s12603-022-1756-1

Year: 2022

Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France

DOI: 10.1371/journal.pone.0261069

Year: 2022

A highly virulent variant of HIV-1 circulating in the Netherlands

DOI: 10.1126/science.abk1688

Year: 2022

Two-year immunogenicity of a pre-exposure rabies vaccination administered as a two-dose schedule.

DOI: 10.1093/jtm/taac029

Year: 2022

Prevalence and Spectrum of Second Primary Malignancies among People Living with HIV in the French Dat’AIDS Cohort

DOI: 10.3390/cancers14020401

Year: 2022

Ergothioneine Improves Aerobic Performance Without Any Negative Effect on Early Muscle Recovery Signaling in Response to Acute Exercise

DOI: 10.3389/fphys.2022.834597

Year: 2022

Determinants of Second Primary Cancer Type in Survivors of Virus-Related and Non-Virus-Related Cancer Living With HIV in the French Dat’AIDS Cohort

DOI: 10.1177/10732748211066310

Year: 2021

Letter to the editor

DOI: 10.1111/hiv.13192

Year: 2021

What are the Challenges in Disease Eradication?

Can Aspirin Be Used for Fever Management?

How Can Personal Hygiene Help in Infection Prevention?

How are Structural Proteins Studied?

When is a Biopsy Indicated?

Are There Vaccines Available for Diseases Transmitted by Aedes Aegypti?

What are the Treatment Options?

What Are the Treatment Options for Infected Newborns?

How Do Infections Resolve?

Why is Biosecurity Important?

Partnered Content Networks

Relevant Topics